Abstract
We report the results of a prospective audit of the rates of postoperative infection in patients having operations for inflammatory bowel disease. Apart from a single prospective controlled trial, all other groups have been studied sequentially using the original placebo control group for comparison. The rate of abdominal wound sepsis when no antibiotic was used was 37 per cent. This was reduced to 23.3 per cent with 24-hour cover using metronidazole and gentamicin. However, only after prolonged use of metronidazole and gentamicin for five days was there a significant reduction in abdominal wound infections to 13.3 per cent. Prophylaxis, using 24-hour cover with metronidazole combined with five-day therapy with mezlocillin, achieved an abdominal wound infection rate of 15.6 per cent. The most recent group of patients studied have received 24-hour cover with metronidazole and five-day exposure to latamoxef. In the last group the rate of abdominal wound infections was only 13.5 per cent and serious postoperative bleeding was recorded in eight patients (15 per cent) compared with serious bleeding in only three of the remaining 129 patients (2.3 per cent). The only patients in whom streptococcal isolates were eliminated were those receiving metronidazole and mezlocillin. The majority of infections was due to antibiotic-sensitive strains ofEscherichia coli. Proteus, andStaphylococcus species.
Similar content being viewed by others
References
Allsop JR, Lee EC. Factors which influence post-operative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids. Gut 1978;19:729–34.
Barker K, Graham NG, Mason MC, et al. The relative significance of pre-operative oral antibiotics, mechanical bowel preparation and pre-operative peritoneal contamination in the avoidance of sepsis after radical surgery for ulcerative colitis and Crohn's disease of the large bowel. Br J Surg 1971;58:270–3.
Higgens C, Allan RN, Keighley MR, Arabi Y, Alexander-Williams J. Sepsis following operation for inflammatory intestinal disease. Dis Colon Rectum 1980;23:102–5.
Fabricius P, Moms DL, Ozuner G, Scammel B, Allan RN, Keighley MRB. Postoperative bleeding and latamoxef prophylaxis in surgery for colorectal disease. Gut (in press).
Hares MM, Bentley S, Allan RN, Burdon DW, Keighley MR. Clinical trials of the efficacy and duration of antibacterial cover for elective resection in inflammatory bowel disease. Br J Surg 1982;62:215–7.
Keighley MR, Eastwood D, Ambrose NS, Burdon DW, Allan RN. Incidence and microbiology of abdominal and pelvic abscess in Crohn's disease. Gastroenterology 1982;3:1271–5.
Panwalker AD, Rosenfeld J. Haemorrhage, diarrhoea and superinfection associated with the use of moxalactam. J Infec Dis 1983;147:171–2.
Weitekamp MR, Aber RC. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA 1983;249:69–71.
Smith CR, Lipsky JJ. Hypothrombinaemia and platelet dysfunction caused by cephalosporin and oxalactam antibiotics. J Antimicrob Chemother 1983;11:496–7.
Author information
Authors and Affiliations
Additional information
Supported by grants from Eli Lilly, May and Baker Ltd., and Bayer UK Ltd.
About this article
Cite this article
Ambrose, N.S., Alexander-Williams, J. & Keighley, M.R.B. Audit of sepsis in operations for inflammatory bowel disease. Dis Colon Rectum 27, 602–604 (1984). https://doi.org/10.1007/BF02553851
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02553851